Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
6.20
+0.12 (1.97%)
At close: Jan 22, 2026, 4:00 PM EST
6.19
-0.01 (-0.16%)
After-hours: Jan 22, 2026, 4:21 PM EST
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $363.21 million as of January 22, 2026. Its market cap has increased by 36.11% in one year.
Market Cap
363.21M
Enterprise Value
205.46M
1-Year Change
36.11%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $363.21M, a decrease of -35.76%. That is a compound annual growth rate of -8.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 356.18M | 16.63% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 352.83M |
| Aardvark Therapeutics | 337.92M |
| Puma Biotechnology | 332.58M |
| AC Immune | 328.49M |
| Zura Bio | 325.77M |
| Candel Therapeutics | 325.00M |
| XOMA Royalty | 323.32M |
| X4 Pharmaceuticals | 320.89M |